Beers M H, Passman L J
Department of Medicine, University of California, Los Angeles.
Drugs. 1990 Dec;40(6):792-9. doi: 10.2165/00003495-199040060-00003.
The association between antihypertensive medications and depression has been recognised for over 40 years. More recently, our understanding of the role of neurotransmitters in the aetiology of depression has helped us understand how antihypertensive drugs cause depression. Biogenic amine depletion is now believed to underlie the organic nature of depression, and many of the drugs used to treat hypertension interfere with this system. There is now compelling evidence that both reserpine and alpha-methyldopa can induce or worsen depression through their actions on the central nervous system. beta-Blockers have also been implicated, but the data supporting the link between these drugs and depression are not as certain. Guanethidine, clonidine, hydralazine, and prazosin appear to pose little risk in causing depression, although rare occurrences have been reported. Diuretics, calcium channel blockers, and angiotensin converting enzyme (ACE) inhibitors appear to have the lowest association with depression and are therefore the drugs of choice when depression is a risk. Physicians should know which drugs introduce the risk of causing or worsening depression. The wide array of medications now available to treat hypertension offers alternatives that pose low risk. All patients receiving medication to treat hypertension should be evaluated periodically for depression, and if depression occurs, medication should be suspected as playing a role in its aetiology.
抗高血压药物与抑郁症之间的关联已被认识超过40年。最近,我们对神经递质在抑郁症病因学中作用的理解,有助于我们明白抗高血压药物是如何导致抑郁症的。生物胺耗竭现在被认为是抑郁症器质性本质的基础,许多用于治疗高血压的药物会干扰这一系统。现在有令人信服的证据表明,利血平和α-甲基多巴均可通过其对中枢神经系统的作用诱发或加重抑郁症。β受体阻滞剂也与此有关,但支持这些药物与抑郁症之间联系的数据并不那么确凿。胍乙啶、可乐定、肼屈嗪和哌唑嗪似乎引起抑郁症的风险很小,尽管有罕见病例报告。利尿剂、钙通道阻滞剂和血管紧张素转换酶(ACE)抑制剂与抑郁症的关联似乎最低,因此当存在抑郁症风险时,它们是首选药物。医生应该知道哪些药物会带来导致或加重抑郁症的风险。现在有各种各样的药物可用于治疗高血压,提供了低风险的替代选择。所有接受抗高血压药物治疗的患者都应定期评估是否患有抑郁症,如果发生抑郁症,应怀疑药物在其病因中起作用。